[Infected necrotizing pancreatitis. Video-assisted retroperitoneal debridement]

Fernando Revoredo Rego1, Gustavo Reaño Paredes1, José De Vinatea De Árdenas1

  • 1Servicio de Cirugía de Páncreas, Bazo y Retroperitoneo, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Perú.

Medicina
|February 21, 2021
PubMed

Insights

Video-assisted retroperitoneal debridement (VARD) offers a safe and effective minimally invasive necrosectomy for infected necrotizing pancreatitis. This approach demonstrates good long-term outcomes with no mortality in a case series.

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Minimally Invasive Surgery

Background:

  • The step-up approach, including antibiotics and minimally invasive necrosectomy, is the standard for infected necrotizing pancreatitis.
  • Video-assisted retroperitoneal debridement (VARD) is a key minimally invasive technique within this approach.

Observation:

  • A case series of 5 patients (2 female, 3 male) with severe acute pancreatitis and infected pancreatic necrosis treated with the step-up approach and VARD.
  • Patient ages ranged from 27 to 60; all had biliary pancreatitis with APACHE II scores from 16 to 20.
  • Percutaneous drainage occurred 4-7 weeks pre-VARD, with one duodenal fistula complication. All necrotizing pancreatitis cases had positive cultures.

Findings:

  • VARD procedures were performed 6-10 weeks after initial presentation; one patient needed two procedures.
  • Two type B pancreatic fistulas occurred post-VARD, managed nonoperatively.
  • No mortality was observed. Long-term follow-up revealed two cases of exocrine and endocrine pancreatic insufficiency.

Implications:

  • VARD is a safe and effective minimally invasive necrosectomy for infected necrotizing pancreatitis.
  • The step-up approach incorporating VARD yields favorable long-term outcomes.
  • VARD represents a significant advancement in managing severe pancreatic necrosis.